Recursion Pharmaceuticals is transforming drug development with its AI-driven automated discovery and phenomics platform, enabling high-throughput screening, image analysis, and compound optimization. The platform's machine learning models analyze cellular images, predict phenotypic outcomes, and identify novel drug candidates for a wide range of diseases. Recursion Pharmaceuticals partners with pharma companies, biotech firms, and research institutions, accelerating projects in rare diseases, oncology, and immunology. With robust data security, scalable infrastructure, and continuous innovation, Recursion Pharmaceuticals is advancing the science of automated drug discovery. SEO keywords: "Recursion Pharmaceuticals AI drug discovery," "AI phenomics platform," "automated compound screening," "AI cellular image analysis," "Recursion Pharmaceuticals innovation."